Plain-English translation of NCT07558915 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new drug called for people with multiple myeloma—a blood cancer—that has become resistant to or stopped working with standard treatments. Researchers want to understand if this medication is safe and how well it works for patients who have already tried several other therapies. The study will gradually increase the dose to find the right amount and watch carefully for any side effects.
Multiple myeloma is a serious blood cancer, and many patients eventually stop responding to the treatments doctors usually try first. This trial exists because patients with resistant forms of the disease urgently need new options, and this medication may offer hope for those who have run out of other choices.
You likely qualify if…
You likely don't qualify if…
You would receive the medication starting at a low dose, which doctors will gradually increase to find the safest and most effective level. Throughout the study, you'll visit the clinic regularly so doctors can check your health, monitor how the medication is working, and watch for any side effects. The trial has two phases: first, researchers will test different doses, and then, once they find the right dose, more patients will be enrolled to confirm it works.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
Australia